Physiological role of RTK transactivation in the central nervous system and neuropsychiatric diseases

Medicine and Dentistry

• Central Nervous System 100%
• Transactivation 85%
• Protein Tyrosine Kinase 85%
• G Protein Coupled Receptor 42%
• Signal Transduction 28%
• Dopamine 28%
• Development 14%
• Receptor 14%
• Biological Product 14%
• Therapeutic Procedure 14%
• Diseases 14%
• Pathophysiology 14%
• Stimulation 14%
• Comprehension 14%
• Receptor Subtype 14%
• Platelet Derived Growth Factor Receptor 14%
• Epidermal Growth Factor 14%
• Platelet Derived Growth Factor 14%
• Synaptic Transmission 14%
• Aspartic Acid 14%
• Central Nervous System Disease 14%
• Dopamine 4 Receptor 14%
• Glutamate Receptor 14%
• Fibroblast Growth Factor 14%
• Genetic Transcription 14%

Neuroscience

• Transactivation 85%
• Receptor Tyrosine Kinase 85%
• Cell Signaling 28%
• Dopamine 28%
• Neurotransmission 28%
• Eicosanoid Receptor 14%
• Aspartic Acid 14%
• Receptor Subtype 14%
• Glutamate Receptor 14%
• Epidermal Growth Factor 14%
• Genetic Transcription 14%
• Platelet-Derived Growth Factor 14%
• Platelet-Derived Growth Factor Receptor 14%
• Dopamine Receptor D4 14%
• Fibroblast Growth Factor 14%
• Neurotrophin 14%

Biochemistry, Genetics and Molecular Biology

• Transactivation 85%
• Receptor Tyrosine Kinase 85%
• Signal Transduction 28%
• Dopamine 28%
• Development 14%
• Comprehension 14%
• Glutamate Receptor 14%
• Epidermal Growth Factor 14%
• Platelet-Derived Growth Factor Receptor 14%
• Genetic Transcription 14%
• Fibroblast Growth Factor 14%
• Platelet-Derived Growth Factor 14%